CABAZITAXEL FRESENIUS KABI
As listed in the register: CABAZITAXEL FRESENIUS KABI 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
20 mg/ml · concentrado para solución para perfusión
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Cabazitaxel
- Made by
- Fresenius Kabi España, S.A.U.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Jevtana). It describes the substance, not this exact product.
Cabazitaxel is a microtubule inhibitor.
Cabazitaxel binds to tubulin and promotes its assembly into microtubules while simultaneously inhibiting disassembly.
Cabazitaxel is extensively metabolized in the liver (>95%), mainly by the CYP3A4/5 isoenzyme (80% to 90%), and to a lesser extent by CYP2C8.
Around 20 metabolites of cabazitaxel are excreted into human urine and feces.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-10-07
Safety of the active substance
From the US prescribing label for the same active substance (Jevtana). It describes the substance, not this exact product.
WARNING: NEUTROPENIA AND HYPERSENSITIVITY WARNING: NEUTROPENIA AND HYPERSENSITIVITY See full prescribing information for complete boxed warning.
The most common fatal adverse reactions in JEVTANA-treated patients were infections (n=5) and renal failure (n=4).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
France3 matching products
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Fresenius Kabi España, S.A.U. |
|---|---|
| Active substance | Cabazitaxel |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 20 mg/ml |
| Form | concentrado para solución para perfusión |
| Classification | L01CD04 · Cancer treatments and immune-system medicines |
| Route | vía intravenosa |
| Marketed | No — authorised but not currently marketed, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | CABAZITAXEL FRESENIUS KABI 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION |
| Nº Registro | 88251 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.